Genetic testing panel
This article was originally published in The Gray Sheet
HHS Secretary's advisory committee on genetic testing (SACGT) will hold its first meeting June 30 on the National Institutes of Health campus in Bethesda. Edward McCabe, MD, an NIH-funded pediatrician at the University of California at Los Angeles, chairs the 13-member panel. Other members include Centers for Disease Control and Prevention's Clinical Laboratory Improvement Advisory Committee member Patricia Charache, MD, and Joann Boughman, PhD, a member of FDA's Medical Devices Advisory Committee. Panelists will report to HHS Assistant Secretary David Satcher, who will give the group its charge June 30. SACGT will meet twice yearly and have an estimated annual budget of $130,000. HHS Secretary Donna Shalala convened the group to advise on "development, validation and regulation of genetic tests," following recommendations by two NIH panels
You may also be interested in...
The addition of the question “Was this device serviced by a third party servicer?” to adverse event reports filed through the US FDA’s electronic Medical Device Reporting system could prove helpful for the agency and device makers, experts tell Medtech Insight. Industry has long complained about poor work performed by servicers – and loudly groused that they’re not regulated.
Attorneys tell Medtech Insight a recent proposal to review regulations every 10 years could lift some burdens from the medical device industry, but warned that the full effects may not be seen for some time.
A nasal spray formulated using compounds already approved by regulatory bodies in Europe and the US can “prevent and slow” transmission of COVID-19, according to UK researchers who are now seeking a partner to commercialize the product.